Dishman Pharmaceuticals and Chemicals' subsidiary Carbogen Amcis AG has acquired Creapharm Parenterals. In an interview to CNBC-TV18, VVS Murthy, chief financial officer of Dishman Pharma says, it is a small R&D formulation development company. The acquisition, he says, is funded trough internal accruals.
first published: Jan 19, 2012 02:44 pm
A collection of the most-viewed Moneycontrol videos.
Live: Nifty slips below 24,800 as breadth weakens; SMIDs underperform | Closing Bell
Live: Nifty eyes broader market volatility, FOMC outcome for next cues | Opening Bell
Live: Nifty recovers 100 pts from day's lows in a choppy session; smallcaps shine | Closing Bell
Live: Can Nifty reclaim 26,000 after RS 7.5 lakh crore selloff? | IndiGo in focus | Opening Bell
